341 related articles for article (PubMed ID: 4914287)
1. The United States Pharmacopeia. Its value to the professions.
Heller WM
JAMA; 1970 Jul; 213(4):576-9. PubMed ID: 4914287
[No Abstract] [Full Text] [Related]
2. GMPs vs GCPs: United States Pharmacopeia General Chapters.
Allen LV
Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791
[No Abstract] [Full Text] [Related]
3. Editorial: Standardization of drug names.
Lewis JR
JAMA; 1974 Jul; 229(5):559-60. PubMed ID: 4406902
[No Abstract] [Full Text] [Related]
4. Public standards for drugs: reflections on their use by the professions and industry.
Miller LC
Hosp Formul; 1976 Mar; 11(3):151-5. PubMed ID: 1026682
[No Abstract] [Full Text] [Related]
5. United States Pharmacopeia and National Formulary standards, Food and Drug Administration regulations, and the quality of drugs.
LEVY G; NELSON E
N Y State J Med; 1961 Dec; 61():4003-8. PubMed ID: 14464760
[No Abstract] [Full Text] [Related]
6. [Andromachus, Galen, Dalibour, Sydenham...: eponyms, as witnesses of an history of the respective galenicals].
Ledermann F
J Pharm Belg; 2004; 59(4):111-9. PubMed ID: 15719828
[No Abstract] [Full Text] [Related]
7. Travelers, Patent Medicines, and Pharmacopeias: American Pharmacy and British India, 1857 to 1931.
Anderson S
Pharm Hist; 2016; 58(3-4):63-82. PubMed ID: 29470025
[No Abstract] [Full Text] [Related]
8. The United States Pharmacopeia.
JAMA; 1970 Mar; 211(9):1537. PubMed ID: 4904976
[No Abstract] [Full Text] [Related]
9. The United States Pharmacopeia 1820-1970.
Am J Hosp Pharm; 1970 Mar; 27(3):223-7. PubMed ID: 4907230
[No Abstract] [Full Text] [Related]
10. [Pharmacopeia and preparations for cutaneous application].
Esnault F; Etchegaray JP; Mallard C
Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S40-5. PubMed ID: 17563714
[No Abstract] [Full Text] [Related]
11. [The doctor's responsibility and risk in the prescribing of drugs].
Aschenbrenner R
Munch Med Wochenschr; 1973 Apr; 115(17):741-6. PubMed ID: 4574431
[No Abstract] [Full Text] [Related]
12. Pharmacy's "hawks" and "doves".
Feldmann EG
J Am Pharm Assoc; 1968 Jul; 8(7):393-4. PubMed ID: 5665320
[No Abstract] [Full Text] [Related]
13. New York State and drug lists: a history of confusion.
Stetler CJ
Med Mark Media; 1978 Sep; 13(9):36, 38, 40 passim. PubMed ID: 10316687
[No Abstract] [Full Text] [Related]
14. [Essential drugs available to all].
Bol Oficina Sanit Panam; 1992; 113(5-6):539-43. PubMed ID: 1296697
[No Abstract] [Full Text] [Related]
15. Drug information and drug performance. The need for standardization and uniformity.
Feldmann EG
J Am Pharm Assoc; 1974 Aug; 14(8):415-6 passim. PubMed ID: 4851443
[No Abstract] [Full Text] [Related]
16. [Drug control in Europe].
Scowen EF
Minerva Med; 1973 Mar; 64(17):885-8. PubMed ID: 4574200
[No Abstract] [Full Text] [Related]
17. AIHP Kremers Award Address 2006. Pharmacovigilance and the missing denominator: the changing context of pharmaceutical risk mitigation.
Daemmrich A
Pharm Hist; 2007; 49(2):61-75. PubMed ID: 18368740
[No Abstract] [Full Text] [Related]
18. Compounding in Ukraine.
Zdoryk OA; Georgiyants VA; Gryzodub OI; Schnatz R
Int J Pharm Compd; 2013; 17(2):124-7. PubMed ID: 23696172
[TBL] [Abstract][Full Text] [Related]
19. Reporting drug defects.
Belson JJ
Hosp Formul; 1975 Feb; 10(2):78-9. PubMed ID: 10316674
[No Abstract] [Full Text] [Related]
20. Justin Lawrence Powers (1895-1981): champion of improved medication standards.
Worthen DB
J Am Pharm Assoc (2003); 2007; 47(2):292-5. PubMed ID: 17510011
[No Abstract] [Full Text] [Related]
[Next] [New Search]
